COVID-19 Vaccine Uptake Trial
NCT05419232 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 262
Last updated 2025-04-10
Summary
The goal of this study is to assess the best COVID-19 vaccine uptake strategy among students, staff and household members that have not been vaccinated.
There is a multitude of recommendations present that highlight different vaccination strategy; however, it is still unclear which strategy is best to increase COVID-19 vaccination rates. We will compare the effectiveness and acceptance of two different communication strategies among unvaccinated students, staff, and their household members.
Conditions
- Vaccination Refusal
- COVID-19
Interventions
- OTHER
-
Short Message Service (SMS) + Website Link Strategy
The intervention we are evaluating is the effectiveness of a participant receiving a SMS + Website Link as a vaccine uptake strategy
- OTHER
-
Phone Call with Peer Strategy
The intervention we are evaluating is the effectiveness of a participant having a phone call with a peer as a vaccine uptake strategy
Sponsors & Collaborators
-
Washington University School of Medicine
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-07-15
- Primary Completion
- 2023-12-31
- Completion
- 2024-05-31
Countries
- United States
Study Locations
More Related Trials
-
Safety, Efficacy of Chadox1 Ncov-19 Vaccine: Rapid Systematic Review and Meta Analysis
NCT05060861 ·Status: UNKNOWN
-
Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells) in Children and Adolescents
NCT05013983 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Increasing Optimal Use of HPV Vaccination in Primary Care
NCT04180462 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate Safety, Tolerability & Immunogenicity of BNT162b2 in Immunocompromised Participants ≥2 Years
NCT04895982 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of AdCLD-CoV19-1 OMI as a Booster: A SARS-CoV-2 (COVID-19) Preventive Vaccine
NCT05576623 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
NCT07300839 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Multilevel Intervention of COVID-19 Vaccine Uptake Among Latinos
NCT06156228 ·Status: TERMINATED ·Phase: NA
-
Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults
NCT04516746 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Reactogenicity and Immunogenicity of a Novel MVA-SARS-2-ST Vaccine Candidate
NCT05226390 ·Status: TERMINATED ·Phase: PHASE1
-
COVID-19: A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities
NCT04860258 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluation of a Single Vaccination of One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) and a Single Dose Level of a 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) in Healthy Adults Aged 65 to <86 Years
NCT01643941 ·Status: COMPLETED ·Phase: PHASE1
-
Platform Trial to Compare Homologous Boost of Authorized COVID-19 Vaccines and Heterologous Boost With UB-612 Vaccine
NCT05293665 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparison of Immunization Quality Improvement Dissemination Study
NCT02432430 ·Status: COMPLETED ·Phase: NA
-
COVID-19 Vaccines Safety Tracking (CoVaST)
NCT04834869 ·Status: RECRUITING
-
Investigating a Vaccine Against COVID-19
NCT04400838 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of Typhoid Conjugate Vaccine Effectiveness in Ghana
NCT04852185 ·Status: RECRUITING ·Phase: PHASE4
-
Safety and Immunogenicity of COVI-VAC as a Booster Dose in Adults Previously Vaccinated Against COVID-19
NCT05233826 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity Study of AdCLD-CoV19: A COVID-19 Preventive Vaccine in Healthy Volunteers
NCT04666012 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
To Evaluate the Safety, and Immunogenicity of Vaccine Candidate Against COVID-19, in Healthy Adults
NCT04885361 ·Status: UNKNOWN ·Phase: PHASE1
-
Adolescents Seeking COVID Vaccination (Teen COVID Vax)
NCT05537103 ·Status: COMPLETED
-
The STOP-HPV Trial 5: Single Arm Evaluation of the Bundle
NCT03609320 ·Status: UNKNOWN ·Phase: NA
-
Safety and Immunogenicity of Q Fever Vaccine
NCT02092142 ·Status: WITHDRAWN ·Phase: PHASE2
-
Non-specific Effects of Rabies Vaccine
NCT03656198 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Learn About New COVID-19 RNA Vaccine Candidates in COVID-19 Vaccine-Experienced Healthy Individuals
NCT05472038 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
NCT01364571 ·Status: COMPLETED ·Phase: PHASE1